Chronic Diseases and Translational Medicine
Chronic Diseases and Translational Medicine (CDTM, ISSN 2095-882X, CN 10-1249/R) is owned by the Chinese Medical Association and published by the Chinese Medical Association Publishing House and KeAi (a scientific media agent co-funded by Elsevier and Science Press Ltd). CDTM is an open access journal, and all articles are published on line first and print version is quarterly. The categories of articles include Editorial, Original Article, Review, Perspective, Correspondence, et al.
Chronic Diseases and Translational Medicine Mission:
To promote the transformation from basic research to clinical practice, and provide a forum for communication among basic, translational, and clinical research practitioners and physicians from all relevant disciplines.
Researchers and management in academia, government, and the biotechnology and pharmaceutical industries; physician scientists; regulators; policy makers; and funding agencies.
Cardiovascular disease, metabolism/diabetes/obesity, neuroscience/neurology/ psychiatry, cancer, respiratory disease, immunology/vaccines, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/ regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.
- Does not allow reviews to be publicly displayed
- Only allows reviewers to display the journal they reviewed for
Interested in reviewing for this journal?
Your interest in reviewing is shared with journals or conferences when they are partnered with us. Learn more.
Editorial board members on Publons
No one has yet noted that they are on Chronic Diseases and Translational Medicine's editorial board. If you're on the editorial board of Chronic Diseases and Translational Medicine, you can add it in your profile settings.
Top reviewers on Publons (Manuscripts reviewed in last 12 months)
No one has yet endorsed Chronic Diseases and Translational Medicine.
Review contents for Chronic Diseases and Translational Medicine are not publicly displayed on Publons, in accordance with their editorial policy.